Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural labor analgesia with low-dose esketamine for prevention of postpartum depression
ChiCTR2000035353Phase 4Not yet recruiting
- Sponsor
- The First People's Hospital of Longquanyi District, Chengdu
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postpartum depression (PPD) and labor pain (4 arms), sponsored by The First People's Hospital of Longquanyi District, Chengdu. Primary endpoints: VSA pain score, Edinburgh Postnatal Depression Scale score and 1 more. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postpartum depression (PPD)labor pain
Beyond the preview
Go deeper on ChiCTR2000035353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035353.